Etomidate Injection · 1,437 days since initial FDA posting
Brand: ETOMIDATE
FDA lists Etomidate Injection as Active Shortage (Gland Pharma Limited).
Availability on file: Available
Etomidate Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Etomidate Injection
- Manufacturer
- Gland Pharma Limited
- Dosage Form
- Injection
- Presentation
- Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)
- Package NDC
- 72266-147-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Oct 5, 2022
- Last Updated
- Sep 29, 2025
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
Nearby, Other Etomidate Shortage Records
Etomidate Injection
Gland Pharma Limited
Injection
Etomidate Injection
Mylan Institutional, a Viatris Company
Injection
Etomidate Injection
Mylan Institutional, a Viatris Company
Injection
Etomidate Injection
Hospira, Inc., a Pfizer Company
Injection
Etomidate Injection
Hospira, Inc., a Pfizer Company
Injection
Etomidate Injection
Hikma Pharmaceuticals USA, Inc.
Injection
FDA reason on file: Distributed by Fosun Pharma USA, Inc. General shortage guidance lives on the tracker hub.